Current Gene Therapy SCIE

Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of diseases. Cell therapy manuscripts can also include application in diseases when cells have been genetically modified. Current Gene Therapy publishes full-length/mini reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of diseases.

Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.

Current Gene Therapy 是一本同行评审的双月刊，面向对疾病基因和细胞治疗的基础研究和临床应用等主要主题感兴趣的学术和工业科学家。细胞疗法手稿还可以包括对细胞进行基因改造后在疾病中的应用。 Current Gene Therapy 发表关于基因转移和基因表达分析、载体开发、细胞基因工程、动物模型和人类临床应用基因和细胞疗法治疗疾病的最新进展的完整/迷你评论和原创研究。< /p>

Current Gene Therapy 发表评论和原创研究，其中包含有关基因和细胞疗法的实验数据。该杂志还包括关于基因和细胞治疗的技术进步、伦理和监管考虑的手稿。评论应该为读者提供对应用于分子医学的任何实验生物学领域的全面评估，这不仅在基因治疗和细胞治疗的特定领域具有重要意义，而且对其他领域的研究人员也很感兴趣。鼓励作者为未来的进步提供自己的评估和愿景。还欢迎对尚未积累大量文献的最新发现进行评论。这些评论为最近基因治疗实验研究的重点主题提供了一个论坛，主要是为了使临床和基础研究人员都能获得这些结果。包含实验数据的手稿应该是原始数据，之前没有发表过。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-遗传学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2021年影响因子为4.676，平均审稿速度为12-16周，近三年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。